Skip to content
Screener

Return on equity at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
46.7%+17.8pp
Alkermes logo
AlkermesALKS
3.9%-20.1pp
Alto Neuroscience logo
Alto NeuroscienceANRO
-38.9%+0.9pp
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
35.7%+2.6pp
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-43.6%+8.2pp
RFL
Rafael Holdings, Inc.RFL
-26.6%-0.8pp

Other financials

Income statement

See full
Net income-$19.1M-259%
EPS (diluted)-$0.67+95.5%

Balance sheet

See full
Cash & equivalents$320.7M
Total debt$3.5M
Total equity$378.7M+481%
Total assets$393.5M

Cash flow

See full
Operating cash flow-$23.3M-187%
CapEx$32.0K+52.4%
Free cash flow-$23.3M-186%

Valuation

See full
Market cap$1.38B+308%
Enterprise value$1.06B

Returns & leverage

See full
Debt / equity
Current ratio35.7×